Antidiabetic Potiential of Moringa and Dom Extract

Deraya University

Status and phase: Completed; Early Phase 1

Conditions: Diabetes

Treatments: Dietary Supplement: MorDom

Study type: Interventional

Funder types: Other

Identifiers

NCT05898750

MorDom

Details and patient eligibility

About

The Antidiabetic potential of Hyphaene thebaica fruits and Moringa oleifera leaves will be investigated in diabetic patients (type 2). The patients will be maintained on tea of both drugs for 6 weeks. The fasting blood glucose levels of patients will be checked on a daily basis. Other blood biomarkers will be also reported such as insulin concentration, Lipid profile, liver enzymes, c-peptide and glycated hemoglobin

Enrollment: 25 patients

Sex: All

Ages: 30 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• diabetic patients type 2

Exclusion criteria

• liver failure
• heart failure
• renal failure

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

25 participants in 2 patient groups

experimental group

Experimental group

Treatment:

Dietary Supplement: MorDom

Control group

No Intervention group